Margaret E Gatti-Mays (Margaret Gatti-Mays)

ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 15

Top Venues

Journal for immunotherapy of cancer

The oncologist

NPJ breast cancer

Current oncology reports

Ohio State University

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Ohio State University Aug 01 2020

United States

Assistant Professor :: Internal Medicine

National Cancer Institute Jul 01 2017 - Jul 31 2020

United States

Assistant Research Physician :: Medical Oncology Service

Publications

Kai C C Johnson, Ai Ni, Dionisia Quiroga, Ashley C Pariser, Preeti K Sudheendra, Nicole O Williams, Sagar D Sardesai, Mathew Cherian, Daniel G Stover, Margaret E Gatti-Mays, Bhuvaneswari Ramaswamy, Maryam Lustberg, Sachin Jhawar, Roman Skoracki, Robert Wesolowski
The survival benefit of adjuvant trastuzumab with or without chemotherapy in the management of small (T1mic, T1a, T1b, T1c), node negative HER2+ breast cancer. NPJ breast cancer 10 (1) (2024)
Kai C C Johnson, Ai Ni, Dionisia Quiroga, Ashley C Pariser, Preeti K Sudheendra, Nicole O Williams, Sagar D Sardesai, Mathew Cherian, Daniel G Stover, Margaret E Gatti-Mays, Bhuvaneswari Ramaswamy, Maryam Lustberg, Sachin Jhawar, Roman Skoracki, Robert Wesolowski
The survival benefit of adjuvant trastuzumab with or without chemotherapy in the management of small (T1mic, T1a, T1b, T1c), node negative HER2+ breast cancer. NPJ breast cancer 10 (1) (2024)
Kai C C Johnson, Ai Ni, Dionisia Quiroga, Ashley C Pariser, Preeti K Sudheendra, Nicole O Williams, Sagar D Sardesai, Mathew Cherian, Daniel G Stover, Margaret E Gatti-Mays, Bhuvaneswari Ramaswamy, Maryam Lustberg, Sachin Jhawar, Roman Skoracki, Robert Wesolowski
The survival benefit of adjuvant trastuzumab with or without chemotherapy in the management of small (T1mic, T1a, T1b, T1c), node negative HER2+ breast cancer. NPJ breast cancer 10 (1) (2024)
Mary L Disis, Sarah F Adams, Jyoti Bajpai, Marcus O Butler, Tyler J Curiel, Shelley A Dodt, Laura Doherty, Leisha A Emens, Claire F Friedman, Margaret E Gatti-Mays, Melissa A Geller, Amir A Jazaeri, Veena S John, Katherine C Kurnit, John B Liao, Hader Mahdi, Anne Mills, Emese Zsiros, Kunle Odunsi
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of gynecologic cancer. Journal for immunotherapy of cancer 11 (6) (2023)
Margaret E Gatti-Mays, Nicholas P Tschernia, Julius Strauss, Ravi A Madan, Fatima H Karzai, Marijo Bilusic, Jason Mark Redman, Houssein Abdul Sater, Charalampos S Floudas, Nicole J Toney, Renee N Donahue, Caroline Jochems, Jennifer L Marté, Deneise Francis, Sheri McMahon, Elizabeth Lamping, Lisa M Cordes, Jeffrey Schlom, James L Gulley
A Phase I Single-Arm Study of Biweekly NHS-IL12 in Patients With Metastatic Solid Tumors. The oncologist (2023)
Anqi Li, Yuzhou Chang, No-Joon Song, Xingjun Wu, Dongjun Chung, Brian P Riesenberg, Maria Velegraki, Giuseppe D Giuliani, Komal Das, Tamio Okimoto, Hyunwoo Kwon, Karthik B Chakravarthy, Chelsea Bolyard, Yi Wang, Kai He, Margaret E Gatti-Mays, Jayajit Das, Yiping Yang, Daniel T Gewirth, Qin Ma, David Carbone, Zihai Li
Selective targeting of GARP-LTGFβ axis in the tumor microenvironment augments PD-1 blockade via enhancing CD8 + T cell antitumor immunity. Journal for immunotherapy of cancer 10 (9) (2022)
Ilana Schlam, Margaret E Gatti-Mays
Immune Checkpoint Inhibitors in the Treatment of Breast Cancer Brain Metastases. The oncologist 27 (7) (2022)
Leisha A Emens, Sylvia Adams, Ashley Cimino-Mathews, Mary L Disis, Margaret E Gatti-Mays, Alice Y Ho, Kevin Kalinsky, Heather L McArthur, Elizabeth A Mittendorf, Rita Nanda, David B Page, Hope S Rugo, Krista M Rubin, Hatem Soliman, Patricia A Spears, Sara M Tolaney, Jennifer K Litton
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of breast cancer. Journal for immunotherapy of cancer 9 (8) (2022)
Jason Mark Redman, Yo-Ting Tsai, Benjamin A Weinberg, Renee N Donahue, Shruti U Gandhy, Margaret E Gatti-Mays, Houssein Abdul Sater, Marijo Bilusic, Lisa M Cordes, Seth M Steinberg, Jennifer L Marte, Caroline Jochems, Sunnie S Kim, John L Marshall, Sheri McMahon, Erica Redmond, Jeffrey Schlom, James L Gulley, Julius Strauss
A Randomized Phase II Trial of mFOLFOX6 + Bevacizumab Alone or with AdCEA Vaccine + Avelumab Immunotherapy for Untreated Metastatic Colorectal Cancer. The oncologist 27 (3) (2022)
Margaret E Gatti-Mays, James L Gulley
Real-world insights on preferred treatments for steroid-refractory immune checkpoint inhibitor-induced pneumonitis. Journal for immunotherapy of cancer 9 (2) (2022)
Julius Strauss, Margaret E Gatti-Mays, Byoung Chul Cho, Andrew Hill, Sébastien Salas, Edward McClay, Jason M Redman, Houssein Abdul Sater, Renee N Donahue, Caroline Jochems, Elizabeth Lamping, Andrea Burmeister, Jennifer L Marté, Lisa M Cordes, Marijo Bilusic, Fatima Karzai, Laureen S Ojalvo, Genevieve Jehl, P Alexander Rolfe, Christian S Hinrichs, Ravi A Madan, Jeffrey Schlom, James L Gulley
Bintrafusp alfa, a bifunctional fusion protein targeting TGF-β and PD-L1, in patients with human papillomavirus-associated malignancies. Journal for immunotherapy of cancer 8 (2) (2021)
Sarah Jenkins, Robert Wesolowski, Margaret E Gatti-Mays
Improving Breast Cancer Responses to Immunotherapy-a Search for the Achilles Heel of the Tumor Microenvironment. Current oncology reports 23 (5) (2021)
Margaret E Gatti-Mays, Fatima H Karzai, Sanaz N Soltani, Alexandra Zimmer, Jeffrey E Green, Min-Jung Lee, Jane B Trepel, Akira Yuno, Stanley Lipkowitz, Jayakumar Nair, Ann McCoy, Jung-Min Lee
A Phase II Single Arm Pilot Study of the CHK1 Inhibitor Prexasertib (LY2606368) in BRCA Wild-Type, Advanced Triple-Negative Breast Cancer. The oncologist 25 (12) (2020)
Margaret E Gatti-Mays, Jason M Redman, Renee N Donahue, Claudia Palena, Ravi A Madan, Fatima Karzai, Marijo Bilusic, Houssein Abdul Sater, Jennifer L Marté, Lisa M Cordes, Sheri McMahon, Seth M Steinberg, Alanvin Orpia, Andrea Burmeister, Jeffrey Schlom, James L Gulley, Julius Strauss
A Phase I Trial Using a Multitargeted Recombinant Adenovirus 5 (CEA/MUC1/Brachyury)-Based Immunotherapy Vaccine Regimen in Patients with Advanced Cancer. The oncologist 25 (6) (2019)
Margaret E Gatti-Mays, Julius Strauss, Renee N Donahue, Claudia Palena, Jaydira Del Rivero, Jason Mark Redman, Ravi A Madan, Jennifer L Marté, Lisa M Cordes, Elizabeth Lamping, Alanvin Orpia, Andrea Burmeister, Eva Wagner, Cesar Pico Navarro, Christopher R Heery, Jeffrey Schlom, James L Gulley
A Phase I Dose-Escalation Trial of BN-CV301, a Recombinant Poxviral Vaccine Targeting MUC1 and CEA with Costimulatory Molecules. Clinical cancer research : an official journal of the American Association for Cancer Research 25 (16) (2019)

Margaret E Gatti-Mays (Margaret Gatti-Mays)

Publication Activity (10 Years)

Top Topics

Top Venues